.Pharmacolibrary.Drugs.S_SensoryOrgans.S01L_OcularVascularDisorderAgents.S01LA02_Anecortave.Anecortave .Pharmacolibrary.Drugs.S_SensoryOrgans.S01L_OcularVascularDisorderAgents.S01LA02_Anecortave.Anecortave| name: | Anecortave | |
| ATC code: | S01LA02 | route: | subconjunctival |
| compartments: | 1 | |
| dosage: | 15 | mg |
| volume of distribution: | 1 | L |
| clearance: | 0 | |
| other parameters in model implementation | ||
Anecortave acetate is a synthetic corticosteroid derivative developed mainly for the treatment of age-related macular degeneration (AMD), specifically for inhibiting angiogenesis in ocular conditions. It was never approved for use and its development was discontinued.
No published peer-reviewed pharmacokinetic studies or human PK data for anecortave acetate are available. Published literature does not provide specific parameters regarding absorption, distribution, metabolism, or excretion in humans.